Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis

Yu Yu Lu, Jin Hua Chen, Chun Ru Chien, William Tzu Liang Chen, Shih Chuan Tsai, Wan Yu Lin, Chia Hung Kao

研究成果: 雜誌貢獻文章

44 引文 (Scopus)

摘要

Aim: The purpose of the present study was to conduct a systematic review and meta-analysis of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in the detection of recurrent colorectal cancer (CRC) rising in patients with elevated CEA. Materials and methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity and specificity and positive and negative likelihood ratios, and summary receiver-operating characteristic curves in the detection of recurrent CRC in patients with elevated CEA. Results: Eleven studies with a total of 510 patients met the inclusion criteria. One hundred and six patients (106/510 = 20.8 %) had true-negative FDG-PET (PET/CT) results in detection of recurrent CRC when rising CEA. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET in the detection of tumor recurrence in CRC patients with elevated CEA were 90.3 % (95 % CI, 85.5-94.0 %), 80.0 % (95 % CI, 67.0-89.6 %), 2.88 (95 % CI, 1.37-6.07), and 0.12 (95 % CI, 0.07-0.20), respectively. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET/CT in the detection of tumor recurrence in CRC patients with elevated CEA were 94.1 % (95 % CI, 89.4-97.1 %), 77.2 % (95 % CI, 66.4-85.9 %), 4.70 (95 % CI, 0.82-12.13), and 0.06 (95 % CI, 0.03-0.13), respectively. Conclusions: Whole-body FDG-PET and PET/CT are valuable imaging tools for the assessment of patients with suspected CRC tumor recurrence based on the increase of CEA.

原文英語
頁(從 - 到)1039-1047
頁數9
期刊International Journal of Colorectal Disease
28
發行號8
DOIs
出版狀態已發佈 - 八月 2013
對外發佈Yes

指紋

Meta-Analysis
Colorectal Neoplasms
Recurrence
Sensitivity and Specificity
MEDLINE
ROC Curve
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

引用此文

Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA : A systematic review and meta-analysis. / Lu, Yu Yu; Chen, Jin Hua; Chien, Chun Ru; Chen, William Tzu Liang; Tsai, Shih Chuan; Lin, Wan Yu; Kao, Chia Hung.

於: International Journal of Colorectal Disease, 卷 28, 編號 8, 08.2013, p. 1039-1047.

研究成果: 雜誌貢獻文章

Lu, Yu Yu ; Chen, Jin Hua ; Chien, Chun Ru ; Chen, William Tzu Liang ; Tsai, Shih Chuan ; Lin, Wan Yu ; Kao, Chia Hung. / Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA : A systematic review and meta-analysis. 於: International Journal of Colorectal Disease. 2013 ; 卷 28, 編號 8. 頁 1039-1047.
@article{2901a2e6e3c54888b64b5e433fbcb35c,
title = "Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis",
abstract = "Aim: The purpose of the present study was to conduct a systematic review and meta-analysis of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in the detection of recurrent colorectal cancer (CRC) rising in patients with elevated CEA. Materials and methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity and specificity and positive and negative likelihood ratios, and summary receiver-operating characteristic curves in the detection of recurrent CRC in patients with elevated CEA. Results: Eleven studies with a total of 510 patients met the inclusion criteria. One hundred and six patients (106/510 = 20.8 {\%}) had true-negative FDG-PET (PET/CT) results in detection of recurrent CRC when rising CEA. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET in the detection of tumor recurrence in CRC patients with elevated CEA were 90.3 {\%} (95 {\%} CI, 85.5-94.0 {\%}), 80.0 {\%} (95 {\%} CI, 67.0-89.6 {\%}), 2.88 (95 {\%} CI, 1.37-6.07), and 0.12 (95 {\%} CI, 0.07-0.20), respectively. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET/CT in the detection of tumor recurrence in CRC patients with elevated CEA were 94.1 {\%} (95 {\%} CI, 89.4-97.1 {\%}), 77.2 {\%} (95 {\%} CI, 66.4-85.9 {\%}), 4.70 (95 {\%} CI, 0.82-12.13), and 0.06 (95 {\%} CI, 0.03-0.13), respectively. Conclusions: Whole-body FDG-PET and PET/CT are valuable imaging tools for the assessment of patients with suspected CRC tumor recurrence based on the increase of CEA.",
keywords = "Carcinoembryonic antigen, FDG-PET, Meta-analysis, PET/CT, Systematic review",
author = "Lu, {Yu Yu} and Chen, {Jin Hua} and Chien, {Chun Ru} and Chen, {William Tzu Liang} and Tsai, {Shih Chuan} and Lin, {Wan Yu} and Kao, {Chia Hung}",
year = "2013",
month = "8",
doi = "10.1007/s00384-013-1659-z",
language = "English",
volume = "28",
pages = "1039--1047",
journal = "International Journal of Colorectal Disease",
issn = "0179-1958",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA

T2 - A systematic review and meta-analysis

AU - Lu, Yu Yu

AU - Chen, Jin Hua

AU - Chien, Chun Ru

AU - Chen, William Tzu Liang

AU - Tsai, Shih Chuan

AU - Lin, Wan Yu

AU - Kao, Chia Hung

PY - 2013/8

Y1 - 2013/8

N2 - Aim: The purpose of the present study was to conduct a systematic review and meta-analysis of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in the detection of recurrent colorectal cancer (CRC) rising in patients with elevated CEA. Materials and methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity and specificity and positive and negative likelihood ratios, and summary receiver-operating characteristic curves in the detection of recurrent CRC in patients with elevated CEA. Results: Eleven studies with a total of 510 patients met the inclusion criteria. One hundred and six patients (106/510 = 20.8 %) had true-negative FDG-PET (PET/CT) results in detection of recurrent CRC when rising CEA. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET in the detection of tumor recurrence in CRC patients with elevated CEA were 90.3 % (95 % CI, 85.5-94.0 %), 80.0 % (95 % CI, 67.0-89.6 %), 2.88 (95 % CI, 1.37-6.07), and 0.12 (95 % CI, 0.07-0.20), respectively. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET/CT in the detection of tumor recurrence in CRC patients with elevated CEA were 94.1 % (95 % CI, 89.4-97.1 %), 77.2 % (95 % CI, 66.4-85.9 %), 4.70 (95 % CI, 0.82-12.13), and 0.06 (95 % CI, 0.03-0.13), respectively. Conclusions: Whole-body FDG-PET and PET/CT are valuable imaging tools for the assessment of patients with suspected CRC tumor recurrence based on the increase of CEA.

AB - Aim: The purpose of the present study was to conduct a systematic review and meta-analysis of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in the detection of recurrent colorectal cancer (CRC) rising in patients with elevated CEA. Materials and methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity and specificity and positive and negative likelihood ratios, and summary receiver-operating characteristic curves in the detection of recurrent CRC in patients with elevated CEA. Results: Eleven studies with a total of 510 patients met the inclusion criteria. One hundred and six patients (106/510 = 20.8 %) had true-negative FDG-PET (PET/CT) results in detection of recurrent CRC when rising CEA. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET in the detection of tumor recurrence in CRC patients with elevated CEA were 90.3 % (95 % CI, 85.5-94.0 %), 80.0 % (95 % CI, 67.0-89.6 %), 2.88 (95 % CI, 1.37-6.07), and 0.12 (95 % CI, 0.07-0.20), respectively. The pooled estimates of sensitivity and specificity and positive and negative likelihood ratios of FDG-PET/CT in the detection of tumor recurrence in CRC patients with elevated CEA were 94.1 % (95 % CI, 89.4-97.1 %), 77.2 % (95 % CI, 66.4-85.9 %), 4.70 (95 % CI, 0.82-12.13), and 0.06 (95 % CI, 0.03-0.13), respectively. Conclusions: Whole-body FDG-PET and PET/CT are valuable imaging tools for the assessment of patients with suspected CRC tumor recurrence based on the increase of CEA.

KW - Carcinoembryonic antigen

KW - FDG-PET

KW - Meta-analysis

KW - PET/CT

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84883556878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883556878&partnerID=8YFLogxK

U2 - 10.1007/s00384-013-1659-z

DO - 10.1007/s00384-013-1659-z

M3 - Article

C2 - 23407908

AN - SCOPUS:84883556878

VL - 28

SP - 1039

EP - 1047

JO - International Journal of Colorectal Disease

JF - International Journal of Colorectal Disease

SN - 0179-1958

IS - 8

ER -